Itami (Diclofenac Sodium)

Diclofenac sodium inhibits the cyclooxygenase‑1 and cyclooxygenase‑2 enzymes in peripheral tissues, which decreases the production of prostaglandins. Lower prostaglandin levels reduce inflammation, pain signalling, and swelling at the site where the gel is applied.

The specific dose and frequency of Itami are determined by the prescribing healthcare professional based on the patient’s condition, age, and treatment response. Patients should follow the prescriber’s instructions and the product label for proper application.

Safety data for topical diclofenac during pregnancy and lactation are limited. Healthcare providers generally advise caution and may recommend alternative therapies unless the potential benefit outweighs any possible risk. Patients should discuss their individual situation with a qualified professional.

To request Itami, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, confirming trade or institutional credentials before providing pricing, availability, shipping details, and any necessary import documentation.

Itami delivers diclofenac sodium directly to the skin, offering localized relief with lower systemic exposure compared with oral NSAIDs. This can reduce the risk of gastrointestinal and cardiovascular side effects common to systemic NSAIDs, while still providing effective analgesia for targeted musculoskeletal conditions.

Itami should be stored at room temperature, below 25 °C, in its original packaging. Keep the container tightly closed, protect it from moisture and direct sunlight, and avoid freezing to maintain product stability.

Apply a thin layer of the gel to the affected skin area, gently massaging until absorbed. Follow the prescriber’s recommended frequency, typically not exceeding the amount specified on the label. Wash hands after application unless the treated area is the hands themselves.

Serious risks, though rare, include severe allergic reactions such as hives, swelling, or difficulty breathing, and rare systemic NSAID effects like gastrointestinal bleeding or renal impairment. If any signs of a serious reaction appear, discontinue use and seek immediate medical attention.

Individuals with known hypersensitivity to diclofenac, other NSAIDs, or any component of the formulation should avoid Itami. It should also not be used on open wounds, infected skin, or extensive body surface areas without medical supervision.